actabiomedicaActa Biomedica ScientificaActa Biomedica Scientifica2541-94202587-9596Scientific Centre for Family Health and Human Reproduction Problems10.29413/ABS.2020-5.5.8actabiomedica-2441Research ArticleНЕВРОЛОГИЯ И НЕЙРОХИРУРГИЯNEUROLOGY AND NEUROSURGERYЧерепно-мозговая травма и нейровоспаление: обзор основных биомаркеровTraumatic Brain Injury and Neuroinflammation: Review of the Main Biomarkershttps://orcid.org/0000-0002-0086-1201ЗудоваА. И.ZudovaA. I.

студентка

620002, г. Екатеринбург, ул. Мира, 19, Россия

620049, г. Екатеринбург, ул. Первомайская, 106, Россия

ul. Mira 19, Yekaterinburg 620002, Russian Federation

 

ul. Pervomayskaya 106, 620046, Yekaterinburg Russia, Russian Federation

tina.zudova@mail.ruhttps://orcid.org/0000-0002-9850-9387СухоросоваА. Г.SukhorosovaA. G.

студентка

620002, г. Екатеринбург, ул. Мира, 19, Россия

620049, г. Екатеринбург, ул. Первомайская, 106, Россия

ul. Mira 19, Yekaterinburg 620002, Russian Federation ul. Pervomayskaya 106, 620046, Yekaterinburg Russia, Russian Federation

https://orcid.org/0000-0002-4900-5019СоломатинаЛ. В.SolomatinaL. V.

620002, г. Екатеринбург, ул. Мира, 19, Россия

620049, г. Екатеринбург, ул. Первомайская, 106, Россия

ul. Mira 19, Yekaterinburg 620002, Russian Federation ul. Pervomayskaya 106, 620046, Yekaterinburg Russia, Russian Federation

slv10@list.ruФГАОУ ВО «Уральский федеральный университет имени первого Президента России Б.Н. Ельцина», Институт естественных наук и математики; ФГБУН Институт иммунологии и физиологии Уральского отделения Российской академии наукInstitute of Natural Sciences and Mathematics, Ural Federal University named after the first President of Russia B.N. Yeltsin; Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences202007112020556067Copyright © Зудова А.И., Сухоросова А.Г., Соломатина Л.В., 20202020Зудова А.И., Сухоросова А.Г., Соломатина Л.В.Zudova A.I., Sukhorosova A.G., Solomatina L.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.actabiomedica.ru/jour/article/view/2441черепно-мозговая травмабиомаркерынейровоспалениеbrain injuriesbiomarkersneuroinflammationРабота выполнена в рамках госзадания ИИФ УрО РАН (регистрационный номер НИОКТР № АААА-А18- 118020590108-7).ReferencesMenon DK, Schwab K, Wright DW, Maas AI, et al. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil. 2010; 91(11): 1637-1640. doi: 10.1016/j.apmr.2010.05.017Menon DK, Schwab K, Wright DW, Maas AI, et al. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil. 2010; 91(11): 1637-1640. doi: 10.1016/j.apmr.2010.05.017Yilmaz C, Karali K, Fodelianaki G, Gravanis A, Chavakis T, Charalampopoulos I, et al. Neurosteroids as regulators of neuroinflammation. Front Neuroendocrinol. 2019; 55: 100788. doi: 10.1016/j.yfrne.2019.100788Yilmaz C, Karali K, Fodelianaki G, Gravanis A, Chavakis T, Charalampopoulos I, et al. Neurosteroids as regulators of neuroinflammation. Front Neuroendocrinol. 2019; 55: 100788. doi: 10.1016/j.yfrne.2019.100788Министерство здравоохранения Российской Федерации. Социально-значимые заболевания населения России в 2018 году (статистические материалы). М.; 2019.Ministry of Health of the Russian Federation. Socially significant diseases of the Russian population in 2018 (statistical materials). M.; 2019. (In Russ.)Лихтерман Л.Б. Классификация черепно-мозговой травмы. Часть II. Современные принципы классификации ЧМТ. Судебная медицина. 2015; 1(3): 37-48.Lichterman L.B. Classification of cranial trauma. Sudebnaya meditsina. 2015; 1(3): 37-48. (In Russ.)Saatman KE, Duhaime AC, Bullock R, Maas AIR, Valadka A, Manley GT, et al. Classification of traumatic brain injury for targeted therapies. J Neurotrauma. 2008; 25(7): 719-738. doi: 10.1089/neu.2008.0586Saatman KE, Duhaime AC, Bullock R, Maas AIR, Valadka A, Manley GT, et al. Classification of traumatic brain injury for targeted therapies. J Neurotrauma. 2008; 25(7): 719-738. doi: 10.1089/neu.2008.0586Schimmel SJ, Acosta S, Lozano D. Neuroinflammation in traumatic brain injury: A chronic response to an acute injury. Brain Circ. 2017; 3(3): 135-142. doi: 10.4103/bc.bc_18_17Schimmel SJ, Acosta S, Lozano D. Neuroinflammation intraumatic brain injury: A chronic response to an acute injury. Brain Circ. 2017; 3(3): 135-142. doi: 10.4103/bc.bc_18_17Ladak AA, Enam SA, Ibrahim MT. A Review of the molecular mechanisms of traumatic brain injury. World Neurosurg. 2019; 131: 126-132. doi: 10.1016/j.wneu.2019.07.039Ladak AA, Enam SA, Ibrahim MT. A Review of the molecular mechanisms of traumatic brain injury. World Neurosurg. 2019; 131: 126-132. doi: 10.1016/j.wneu.2019.07.039Sahel DK, Kaira M, Raj K, Sharma S, Singh S. Mitochondrial dysfunctioning and neuroinflammation: recent highlights on the possible mechanisms involved in traumatic brain injury. Neurosci Lett. 2019; 710: 134347. doi: 10.1016/j.neulet.2019.134347Sahel DK, Kaira M, Raj K, Sharma S, Singh S. Mitochondrial dysfunctioning and neuroinflammation: recent highlights on the possible mechanisms involved in traumatic brain injury. Neurosci Lett. 2019; 710: 134347. doi: 10.1016/j.neulet.2019.134347Nasr IW, Chun Y, Kannan S. Neuroimmune responses in the developing brain following traumatic brain injury. Exp Neurol. 2019; 320: 112957. doi: 10.1016/j.expneurol.2019.112957Nasr IW, Chun Y, Kannan S. Neuroimmune responses in the developing brain following traumatic brain injury. Exp Neurol. 2019; 320: 112957. doi: 10.1016/j.expneurol.2019.112957Needham EJ, Helmy A, Zanier ER, Jones JL, Coles AJ, Menon DK. The immunological response to traumatic brain injury. J Neuroimmunol. 2019; 332: 112-125. doi: 10.1016/j.jneuroim.2019.04.005Needham EJ, Helmy A, Zanier ER, Jones JL, Coles AJ, Menon DK. The immunological response to traumatic brain injury. J Neuroimmunol. 2019; 332: 112-125. doi: 10.1016/j.jneuroim.2019.04.005Pearn ML, Niesman IR, Egawa J, Sawada A, AlmenarQueralt A, Shah SB, et al. Pathophysiology associated with traumatic brain injury: current treatments and potential novel therapeutics. Cell Mol Neurobiol. 2017; 37(4): 571-585. doi: 10.1007/s10571-016-0400-1Pearn ML, Niesman IR, Egawa J, Sawada A, AlmenarQueralt A, Shah SB, et al. Pathophysiology associated with traumatic brain injury: current treatments and potential novel therapeutics. Cell Mol Neurobiol. 2017; 37(4): 571-585. doi: 10.1007/s10571-016-0400-1Russo MV, McGavern DB. Inflammatory neuroprotection following traumatic brain injury. Science. 2016; 353(6301): 783- 755. doi: 10.1126/science.aaf6260Russo MV, McGavern DB. Inflammatory neuroprotection following traumatic brain injury. Science. 2016; 353(6301): 783-755. doi: 10.1126/science.aaf6260Dinet V, Petry KG, Badaut J. Brain-immune interactions and neuroinflammation after traumatic brain injury. Front Neurosci. 2019; 13: 1178. doi: 10.3389/fnins.2019.01178Dinet V, Petry KG, Badaut J. Brain-immune interactions and neuroinflammation after traumatic brain injury. Front Neurosci. 2019; 13: 1178. doi: 10.3389/fnins.2019.01178Casault C, Al Sultan AS, Banoei M, Couillard P, Kramer A, Winston BW. Cytokine responses in severe traumatic brain injury: where there is smoke, is there fire? Neurocrit Care. 2019; 30(1): 22-32. doi: 10.1007/s12028-018-0522-zCasault C, Al Sultan AS, Banoei M, Couillard P, Kramer A, Winston BW. Cytokine responses in severe traumatic brain injury: where there is smoke, is there fire? Neurocrit Care. 2019; 30(1): 22-32. doi: 10.1007/s12028-018-0522-zRodney T, Osier N, Gill J. Pro- and anti-inflammatory biomarkers and traumatic brain injury outcomes: A review. Cytokine. 2018; 110: 248-256. doi: 10.1016/j.cyto.2018.01.012Rodney T, Osier N, Gill J. Pro- and anti-inflammatory biomarkers and traumatic brain injury outcomes: A review. Cytokine. 2018; 110: 248-256. doi: 10.1016/j.cyto.2018.01.012Bogoslovsky T, Gill J, Jeromin A, Davis C, Diaz-Arrastia R. Fluid biomarkers of traumatic brain injury and intended context of use. Diagnostics (Basel). 2016; 6(4): 37. doi: 10.3390/diagnostics6040037Bogoslovsky T, Gill J, Jeromin A, Davis C, Diaz-Arrastia R. Fluid biomarkers of traumatic brain injury and intended context of use. Diagnostics (Basel). 2016; 6(4): 37. doi: 10.3390/diagnostics6040037Yang DB, Yu WH, Dong XQ, Zhang ZY, Du Q, Zhu Q, et al. Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury. Clin Chim Acta. 2017; 469: 99-104. doi: 10.1016/j.cca.2017.03.030Yang DB, Yu WH, Dong XQ, Zhang ZY, Du Q, Zhu Q, et al. Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury. Clin Chim Acta. 2017; 469: 99-104. doi: 10.1016/j.cca.2017.03.030Feng MJ, Ning W Bin, Wang W, Lv ZH, Liu XB, Zhu Y, et al. Serum S100A12 as a prognostic biomarker of severe traumatic brain injury. Clin Chim Acta. 2018; 480: 84-91. doi: 10.1016/j.cca.2018.01.044Feng MJ, Ning W Bin, Wang W, Lv ZH, Liu XB, Zhu Y, et al. Serum S100A12 as a prognostic biomarker of severe traumatic brain injury. Clin Chim Acta. 2018; 480: 84-91. doi: 10.1016/j.cca.2018.01.044Di Battista AP, Rhind SG, Hutchison MG, Hassan S, Shiu MY, Inaba K, et al. Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J Neuroinflammation. 2016; 13: 40. doi: 10.1186/s12974-016-0500-3Di Battista AP, Rhind SG, Hutchison MG, Hassan S, Shiu MY, Inaba K, et al. Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J Neuroinflammation. 2016; 13: 40. doi: 10.1186/s12974-016-0500-3Lagerstedt L, Egea-Guerrero JJ, Rodríguez-Rodríguez A, Bustamante A, Montaner J, El Rahal A, et al. Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury. PLoS One. 2018; 13(2): e0193278. doi: 10.1371/journal.pone.0193278Lagerstedt L, Egea-Guerrero JJ, Rodríguez-Rodríguez A, Bustamante A, Montaner J, El Rahal A, et al. Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury. PLoS One. 2018; 13(2): e0193278. doi: 10.1371/journal.pone.0193278Banoei MM, Casault C, Metwaly SM, Winston BW. Metabolomics and biomarker discovery in traumatic brain injury. J Neurotrauma. 2018; 35(16): 1831-1848. doi: 10.1089/neu.2017.5326Banoei MM, Casault C, Metwaly SM, Winston BW. Metabolomics and biomarker discovery in traumatic brain injury. J Neurotrauma. 2018; 35(16): 1831-1848. doi: 10.1089/neu.2017.5326Anada RP, Wong KT, Jayapalan JJ, Hashim OH, Ganesan D. Panel of serum protein biomarkers to grade the severity of traumatic brain injury. Electrophoresis. 2018; 39(18): 2308-2315. doi: 10.1002/elps.201700407Anada RP, Wong KT, Jayapalan JJ, Hashim OH, Ganesan D. Panel of serum protein biomarkers to grade the severity of traumatic brain injury. Electrophoresis. 2018; 39(18): 2308-2315. doi: 10.1002/elps.201700407Huie JR, Diaz-Arrastia R, Yue JK, Sorani MD, Puccio AM, Okonkwo DO, et al. Testing a multivariate proteomic panel for traumatic brain injury biomarker discovery: a TRACK-TBI pilot study. J Neurotrauma. 2019; 36(1): 100-110. doi: 10.1089/neu.2017.5449Huie JR, Diaz-Arrastia R, Yue JK, Sorani MD, Puccio AM, Okonkwo DO, et al. Testing a multivariate proteomic panel for traumatic brain injury biomarker discovery: a TRACK-TBI pilot study. J Neurotrauma. 2019; 36(1): 100-110. doi: 10.1089/neu.2017.5449Corrigan F, Mander KA, Leonard AV, Vink R. Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. J Neuroinflammation. 2016; 13(1): 264. doi: 10.1186/s12974-016-0738-9Corrigan F, Mander KA, Leonard AV, Vink R. Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. J Neuroinflammation. 2016; 13(1): 264. doi: 10.1186/s12974-016-0738-9Vink R, Gabrielian L, Thornton E. The role of substance P in secondary pathophysiology after traumatic brain injury. Front Neurol. 2017; 8: 304. doi: 10.3389/fneur.2017.00304Vink R, Gabrielian L, Thornton E. The role of substance P in secondary pathophysiology after traumatic brain injury. Front Neurol. 2017; 8: 304. doi: 10.3389/fneur.2017.00304Jassam YN, Izzy S, Whalen M, McGavern DB, El Khoury J. Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron. 2017; 95(6): 1246‐1265. doi: 10.1016/j.neuron.2017.07.010Jassam YN, Izzy S, Whalen M, McGavern DB, El Khoury J. Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron. 2017; 95(6): 1246‐1265. doi: 10.1016/j.neuron.2017.07.010

The authors declare that there are no conflicts of interest present.